salesforce.com (NYSE:CRM) Research Coverage Started at UBS Group

Advertisement

BEGIN ARTICLE PREVIEW:

Research analysts at UBS Group initiated coverage on shares of salesforce.com (NYSE:CRM) in a research note issued on Wednesday, Benzinga reports. The brokerage set a “buy” rating and a $325.00 price target on the CRM provider’s stock. UBS Group’s price target would indicate a potential upside of 21.80% from the company’s current price.Several other research analysts also recently commented on the company. BMO Capital Markets upped their price target on salesforce.com from $213.00 to $230.00 and gave the stock an “outperform” rating in a report on Friday, August 21st. Royal Bank of Canada upped their target price on shares of salesforce.com from $220.00 to $275.00 and gave the company an “outperform” rating in a research note on Wednesday, August 26th. Sanford C. Bernstein restated a “neutral” rating and issued a $186.00 price target on shares of salesforce.com in a research report on Monday, June 22nd. Canaccord Genuity boosted their price objective on shares of salesforce.com from $200.00 to $270.00 and gave the stock a “buy” rating in a report on Wednesday, August 26th. Finally, Oppenheimer increased their target price on shares of salesforce.com from $205.00 to $265.00 and gave the company an “outperform” rating in a research note on Wednesday, August 26th. Two …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE